Autoreactive T cells in human smokers is predictive of clinical outcome

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Xu, Chuang ^a   Hesselbacher, Sean ^a   Tsai, Chu Lin ^b   Shan, Ming ^a   Spitz, Margaret ^a   Scheurer, Michael ^a   Roberts, Luz ^a   Perusich, Sarah ^a,c   Zarinkamar, Nazanin ^a,c   Coxson, Harvey ^d   Krowchuk, Natasha ^d   Corry, David B ^a   Kheradmand, Farrah ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autoreactive T cells; Emphysema; Humans; Immuno assays; T cell cloning; Tetramers; Th1; Th17

Indexed keywords

EID: 84874197063     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00267     Document Type: Article

References (62)

1. Agusti, A., Calverley, P. M. A., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., Silverman, E. K., Tal-Singer, R., Wouters, E., Yates, J. C., Vestbo, J., and Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. (2010). Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 11, 122.
2. Alcorn, J. F., Crowe, C. R., and Kolls, J. K. (2009). TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72, 495-516.
3. Bizbiz, L., Alperovitch, A., and Robert, L. (1997). Aging of the vascular wall: serum concentration of elastin pep-tides and elastase inhibitors in relation to cardiovascular risk factors. The EVA study. Atherosclerosis 131, 73-78.
4. Chang, S. H., and Dong, C. (2011). Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell. Signal. 23, 1069-1075.
5. Churg, A., Cosio, M., and Wright, J. L. (2008). Mechanisms of cigarette smoke-induced COPD: insights from animal models. Am. J. Phys-iol. Lung Cell Mol. Physiol. 294, L612-L631.
6. Coxson, H. O., Mayo, J. R., Behzad, H., Moore, B. J., Verburgt, L. M., Staples, C. A., Pare, P. D., and Hogg, J. C. (1995). Measurement of lung expansion with computed tomography and comparison with quantitative histology. J. Appl. Physiol. 79, 1525-1530.
7. Coxson, H.O.,andRogers, R.M. (2005). Quantitative computed tomography of chronic obstructive pulmonary disease. Acad. Radiol. 12, 1457-1463.
8. Coxson, H. O., Rogers, R. M., Whittall, K. P., D'Yachkova, Y., Pare, P. D., Sci-urba, F. C., and Hogg, J. C. (1999). A quantification of the lung surface area in emphysema using computed tomography. Am. J. Respir. Crit. Care Med. 159, 851-856.
9. Crapo, R., Enright, P., and Zeballos, J. (2002). ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Cell Mol. Biol. 166, 111-117.
10. Debret, R., Antonicelli, F., Theill, A., Hornebeck, W., Bernard, P., Guenounou, M., and Le Naour, R. (2005). Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler. Thromb. Vasc. Biol. 25, 1353-1358.
11. Del Prete, G., De Carli, M., D'Elios, M. M., Maestrelli, P., Ricci, M., Fabbri, L., and Romagnani, S. (1993). Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur. J. Immunol. 23, 1445-1449.
12. Durant, L., Watford, W. T., Ramos, H. L., Laurence, A., Vahedi, G., Wei, L., Takahashi, H., Sun, H.-W., Kanno, Y., Powrie, F., and O'Shea, J. J. (2010). Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32, 605-615.
13. Freeman, C. M., Curtis, J. L., and Chen-sue, S. W. (2007). CC chemokine receptor 5 and CXC chemokine receptor 6 expression by lung CD8+ cells correlates with chronic obstructive pulmonary disease severity. Am. J. Pathol. 171, 767-776.
14. Galkina, E., and Ley, K. (2009). Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27, 165-197.
15. Gevenois, P. A., de Maertelaer, V., De Vuyst, P., Zanen, J., and Yernault, J. C. (1995). Comparison of computed densityand macroscopicmor-phometry in pulmonary emphysema. Am. J. Respir. Crit. Care Med. 152, 653-657.
16. Gevenois, P.A., DeVuyst, P., De Maerte-laer, V., Zanen, J., Jacobovitz, D., Cosio, M. G., and Yernault, J. C. (1996). Comparison of computed density and microscopic morphom-etry in pulmonary emphysema. Am. J. Respir. Crit. Care Med. 154, 187-192.
17. GOLD Executive Committee. (2008). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Available at: http://www.goldcopd.org/
18. Grumelli, S., Corry, D. B., Song, L. Z., Song, L., Green, L., Huh, J., Hacken, J., Espada, R., Bag, R., Lewis, D. E., and Kheradmand, F. (2004). An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 1, e8. doi:10.1371/journal.pmed.0010008
19. Guerassimov, A., Hoshino, Y., Takubo, Y., Turcotte, A., Yamamoto, M., Ghezzo, H., Triantafillopoulos, A., Whittaker, K., Hoidal, J. R., and Cosio, M. G. (2004). The development of emphysema in cigarette smoke-exposed miceisstraindepen-dent. Am. J. Respir. Crit. Care Med. 170, 974-980. [See comment].
20. Han, M. K., Agusti, A., Calverley, P. M., Celli, B. R., Criner, G., Curtis, J. L., Fabbri, L. M., Goldin, J. G., Jones, P. W., MacNee, W., Make, B. J., Rabe, K. F., Rennard, S. I., Sci-urba, F. C., Silverman, E. K., Vestbo, J., Washko, G. R., Wouters, E. F. M., and Martinez, F. J. (2010). Chronic obstructive pulmonary disease phe-notypes: the future of COPD. Am. J. Respir. Crit. Care Med. 182, 598-604.
21. Harrison, O. J., Foley, J., Bolognese, B. J., Long, E. III, Podolin, P. L., and Walsh, P. T. (2008). Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunol. Lett. 121, 13-21.
22. He, J. Q., Foreman, M. G., Shuman-sky, K., Zhang, X., Akhabir, L., Sin, D. D., Man, S. F. P., Demeo, D. L., Litonjua, A. A., Silverman, E. K., Connett, J. E., Anthonisen, N. R., Wise, R. A., Pare, P. D., and Sand-ford, A. J. (2009). Associations of IL6 polymorphisms with lung function decline and COPD. Thorax 64, 698-704.
23. Hesselbacher, S., Ross, R., Schabath, M., Smith, E., Perusich, S., Barrow, N., Smithwick, P., Mammen, M., Cox-son, H., Krowchuk, N., Corry, D. B., and Kheradmand, F. (2011). Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysemainever-smokers. Int. J. Environ. Res. Public Health 8, 1324-1340.
24. Highland, K., Strange, C., and Heffner, J. (2003). Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann. Intern. Med. 138, 969-973.
25. Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., and Pare, P. D. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350, 2645-2653.
26. Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., Psoriasis Study Group, Durez, P., Tak, P. P., Gomez-Reino, J. J., Rheumatoid Arthritis Study Group, Foster, C. S., Kim, R. Y., Samson, C. M., Falk, N. S., Chu, D. S., Callanan, D., Nguyen, Q. D., Uveitis Study Group, Rose, K., Haider, A., and Di Padova, F. (2010). Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2, 52ra72.
27. Kamogawa, Y., Minasi, L. E., Carding, S. R., Bottomly, K., and Flavell, R. A. (1993). The relationship of IL-4- and IFNγ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75, 985-995.
28. Kaser, A., Zeissig, S., and Blumberg, R. S. (2010). Inflammatorybowel disease. Annu. Rev. Immunol. 28, 573-621.
29. Kelsen, S. G., Aksoy, M. O., Georgy, M., Hershman, R., Ji, R., Li, X., Hurford, M., Solomides, C., Chatila, W., and Kim, V. (2009). Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3. Am. J. Respir. Crit. Care Med. 179, 799-805.
30. Kheradmand, F., Shan, M., Xu, C., and Corry, D. (2012). Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. Expert Rev. Clin. Immunol. 8, 285-292.
31. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517.
32. Kucich, U., Rosenbloom, J., Kimbel, P., Weinbaum, G., and Abrams, W. R. (1991). Size distribution of human lung elastin-derived peptide antigens generated in vitro and in vivo. Am. Rev. Respir. Dis. 143, 279-283.
33. Lapperre, T. S., Snoeck-Stroband, J. B., Gosman, M. M., Jansen, D. F., Van Schadewijk, A., Thiadens, H. A., Vonk, J. M., Boezen, H. M., Ten Hacken, N. H., Sont, J. K., Rabe, K. F., Kerstjens, H. A., Hiemstra, P. S., Timens, W., Postma, D. S., and Sterk, P. J. (2009). Effect of fluti-casone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 151, 517-527.
34. Lee, S.-H., Goswami, S., Grudo, A., Song, L.-Z., Bandi, V., Goodnight-White, S., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., Coxson, H. O., Cogswell, S., Storness-Bliss, C., Corry, D. B., and Kheradmand, F. (2007). Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat. Med. 13, 567-569.
35. Lettre, G., and Rioux, J. D. (2008). Autoimmune diseases: insights from genome-wide association studies. Hum. Mol. Genet. 17, R116-R121.
36. Lindholt, J. S., Heegaard, N. H., Vam-men, S., Fasting, H., Henneberg, E. W., and Heickendorff, L. (2001a). Smoking, but not lipids, lipopro-tein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 21, 51-56.
37. Lindholt, J. S., Heickendorff, L., Vam-men, S., Fasting, H., and Henneberg, E. W. (2001b). Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. 21, 235-240.
38. Littman, D. R., and Rudensky, A. Y. (2010). Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858.
39. Mariotti, S., and Nisini, R. (2009). Generation of human T cell clones. Methods Mol. Biol. 514, 65-93.
40. MohamedHoesein, F.A.A.,deHoop, B., Zanen, P., Gietema, H., Kruitwagen, C. L. J. J., van Ginneken, B., Isgum, I., Mol, C., van Klaveren, R. J., Dijkstra, A. E., Groen, H. J.M., Boezen, H. M., Postma, D. S., Prokop, M., and Lam-mers, J.-W. J. (2011). CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 66, 782-787.
41. Muller, K. M., Jaunin, F., Masouye, I., Saurat, J. H., and Hauser, C. (1993). Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol. 150, 5576-5584.
42. Nishimura, M., Makita, H., Nagai, K., Konno, S., Nasuhara, Y., Hasegawa, M., Shimizu, K., Betsuyaku, T., Ito, Y. M., Fuke, S., Igarashi, T., Akiyama, Y., Ogura, S., and Hokkaido COPD Cohort Study Investigators. (2012). Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmoanry disease.Am. J. Respir. Cell Mol. Biol.185, 44-52.
43. Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., Jensen, R., Johnson, D. C., MacIntyre, N., McKay, R., Miller, M. R., Navajas, D., Pedersen, O. F., and Wanger, J. (2005). Interpretative strategies for lung function tests. Eur. Respir. J. 26, 948-968.
44. Petersen, E., Wagberg, F., and Angquist, K. A. (2002). Serum concentrations of elastin-derived peptides in patients with specific manifestations of atherosclerotic disease. Eur. J. Vasc. Endovas. Surg. 24, 440-444.
45. Rosenbloom, J., Campbell, E. J., Mum-ford, R., Saldeen, T., Senior, R. M., Starcher, B., and Stone, P. (1991). Biochemical/immunologic markers of emphysema. Ann. N. Y. Acad. Sci. 624(Suppl.), 7-12.
46. Saetta, M.,diStefano, A., Turato, G., Fac-chini, F. M., Corbino, L., Mapp, C. E., Maestrelli, P., Ciaccia, A., and Fabbri, L. M. (1998). CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157, 822-826.
47. Senior, R. M., Griffin, G. L., Mecham, R. P., Wrenn, D. S., Prasad, K. U., and Urry, D. W. (1984). Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibrob-lasts and monocytes. J. Cell Biol. 99, 870-874.
48. Shan, M., Cheng, H. F., Song, L. Z., Roberts, L., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., Coxson, H. O., Storness-Bliss, C., Ramchan-dani, M., Lee, S. H., Corry, D. B., and Kheradmand, F. (2009). Lung myeloid dendritic cells coordinately induce TH1 and TH17 responses in human emphysema. Sci. Transl. Med. 1, 4ra10.
49. Shan, M., Yuan, X., Song, L., Roberts, L., Zarinkamar, N., Seryshev, A., Zhang, Y., Hilsenbeck, S., Chang, S., Dong, C., Corry, D., and Kheradmand, F. (2012). Cigarette smoke induction of osteopontin (SPP1) mediates Th17 inflammation in human and experimental emphysema. Sci. Transl. Med. 4, 117ra9.
50. Starcher, B. C., and Galione, M. J. (1976). Purification and comparison of elastins from different animal species. Anal. Biochem. 74, 441-447.
51. Toh, M. L., and Miossec, P. (2007). The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr. Opin. Rheumatol. 19, 284-288.
52. Trainor, K. J., and Morley, A. A. (1983). Cloning of lymphocytes from whole blood by limiting dilution. J. Immunol. Methods 65, 369-372.
53. Uhlig, H. H., and Powrie, F. (2009). Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Eur. J. Immunol. 39, 2021-2026.
54. van Houwelingen, A. H., Weathing-ton, N. M., Verweij, V., Blalock, J. E., Nijkamp, F. P., and Folkerts, G. (2008). Induction of lung emphysema is prevented by L-arginine-threonine-arginine. FASEB J. 22, 3403-3408.
55. Vestbo, J., Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Cox-son, H. O., Crim, C., Lomas, D. A., MacNee, W., Miller, B. E., Silverman, E. K., Tal-Singer, R., Wouters, E., Rennard, S. I., and ECLIPSE Investigators. (2011). Changes in forced expiratory volume in 1 second over time in COPD. N. Engl. J. Med. 365, 1184-1192.
56. Vrhovski, B., and Weiss, A. S. (1998). Biochemistry of tropoelastin. Eur. J. Biochem. 258, 1-18. [Review; 233 refs].
57. Walston, J. D., Fallin, M. D., Cushman, M., Lange, L., Psaty, B., Jenny, N., Browner, W., Tracy, R., Durda, P.,and Reiner, A. (2007). IL-6 gene variation is associated with IL-6 and C-reactive protein levels but not cardiovascular outcomes in the Cardiovascular Health Study. Hum. Genet. 122, 485-494.
58. Weathington, N. M., Van Houwelin-gen, A. H., Noerager, B. D., Jackson, P. L., Kraneveld, A. D., Galin, F. S., Folkerts, G., Nijkamp, F. P., and Blalock, J. E. (2006). A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat. Med. 12, 317-323.
59. Yamada, H., Nakashima, Y., Okazaki, K., Mawatari, T., Fukushi, J. I., Kaibara, N., Hori, A., Iwamoto, Y., and Yoshikai, Y. (2008). Th1 but not Th17 cells predominate in the joints of patients with rheumatoid arthritis. Ann. Rheum. Dis. 67, 1299-1304.
60. Youden, W. (1950). Index for rating diagnostic tests. Cancer 3, 32-35.
61. Yuan, R., Hogg, J. C., Pare, P. D., Sin, D. D., Wong, J. C., Nakano, Y., McWilliams, A. M., Lam, S., and Coxson, H. O. (2009). Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax 64, 944-949.
62. Yuan, R., Mayo, J. R., Hogg, J. C., Pare, P. D., McWilliams, A. M., Lam, S., and Coxson, H. O. (2007). The effects of radiation dose and CT manufacturer on measurements of lung densitometry. Chest 132, 617-623.